144 related articles for article (PubMed ID: 10435781)
21. Induction of Fos-like immunoreactivity by opioids in guinea-pig brain.
Bot G; Chahl LA
Brain Res; 1996 Aug; 731(1-2):45-56. PubMed ID: 8883853
[TBL] [Abstract][Full Text] [Related]
22. Differential distribution of Fos expression within the male rat preoptic area and hypothalamus in response to physical vs. psychological stress.
Briski K; Gillen E
Brain Res Bull; 2001 Jun; 55(3):401-8. PubMed ID: 11489348
[TBL] [Abstract][Full Text] [Related]
23. Morphine withdrawal precipitated by specific mu, delta or kappa opioid receptor antagonists: a c-Fos protein study in the rat central nervous system.
Le Guen S; Gestreau C; Besson JM
Eur J Neurosci; 2003 Jun; 17(11):2425-37. PubMed ID: 12814374
[TBL] [Abstract][Full Text] [Related]
24. Fedotozine, a kappa-opioid agonist, prevents spinal and supra-spinal Fos expression induced by a noxious visceral stimulus in the rat.
Bonaz B; Rivière PJ; Sinniger V; Pascaud X; Junien JL; Fournet J; Feuerstein C
Neurogastroenterol Motil; 2000 Apr; 12(2):135-47. PubMed ID: 10771495
[TBL] [Abstract][Full Text] [Related]
25. Intraventricular lactate infusion attenuates the transactivational effects of the glucose antimetabolite, 2-deoxy-D-glucose, on hypothalamic vasopressinergic neurons.
Briski KP
Brain Res; 1999 Aug; 839(2):341-5. PubMed ID: 10519059
[TBL] [Abstract][Full Text] [Related]
26. Effects of estradiol on glucoprivic transactivation of catecholaminergic neurons in the female rat caudal brainstem.
Briski KP; Marshall ES; Sylvester PW
Neuroendocrinology; 2001 Jun; 73(6):369-77. PubMed ID: 11408778
[TBL] [Abstract][Full Text] [Related]
27. Pharmacological manipulation of central nitric oxide/guanylate cyclase activity alters Fos expression by rat hypothalamic vasopressinergic neurons during acute glucose deprivation.
Briski KP
J Chem Neuroanat; 1999 Sep; 17(1):13-9. PubMed ID: 10569236
[TBL] [Abstract][Full Text] [Related]
28. Hindbrain neuroglucopenia elicits site-specific transcriptional activation of glutamate decarboxylase-immunopositive neurons in the septopreoptic area of female rat brain.
Briski KP; Singh SR
Neuroendocrinology; 2008; 87(2):113-20. PubMed ID: 17934249
[TBL] [Abstract][Full Text] [Related]
29. Selective alterations in macronutrient intake of food-deprived or glucoprivic rats by centrally-administered opioid receptor subtype antagonists in rats.
Koch JE; Bodnar RJ
Brain Res; 1994 Sep; 657(1-2):191-201. PubMed ID: 7820618
[TBL] [Abstract][Full Text] [Related]
30. Infusion of beta-FNA into the thalamus attenuates morphine-induced c-Fos induction in the rat caudate putamen.
Frankel PS; Garcia MM; Harlan RE
Brain Res; 1999 Aug; 838(1-2):222-6. PubMed ID: 10446338
[TBL] [Abstract][Full Text] [Related]
31. Oxytocin and vasopressin neurones in principal and accessory hypothalamic magnocellular structures express Fos-immunoreactivity in response to acute glucose deprivation.
Briski KP; Brandt JA
J Neuroendocrinol; 2000 May; 12(5):409-14. PubMed ID: 10792579
[TBL] [Abstract][Full Text] [Related]
32. Combined blockade of both micro - and kappa-opioid receptors prevents the acute orexigenic action of Agouti-related protein.
Brugman S; Clegg DJ; Woods SC; Seeley RJ
Endocrinology; 2002 Nov; 143(11):4265-70. PubMed ID: 12399421
[TBL] [Abstract][Full Text] [Related]
33. Effects of opioid receptor antagonists on the effects of i.v. morphine on carrageenin evoked c-Fos expression in the superficial dorsal horn of the rat spinal cord.
Catheline G; Le Guen S; Besson JM
Brain Res; 1999 Apr; 824(1):105-11. PubMed ID: 10095048
[TBL] [Abstract][Full Text] [Related]
34. Induction of Fos immunoreactivity labeling in rat forebrain metabolic loci by caudal fourth ventricular infusion of the monocarboxylate transporter inhibitor, alpha-cyano-4-hydroxycinnamic acid.
Briski KP; Patil GD
Neuroendocrinology; 2005; 82(1):49-57. PubMed ID: 16401911
[TBL] [Abstract][Full Text] [Related]
35. Central glucoprivation evoked by administration of 2-deoxy-D-glucose induces expression of the c-fos gene in a subpopulation of neuropeptide Y neurons in the rat hypothalamus.
Minami S; Kamegai J; Sugihara H; Suzuki N; Higuchi H; Wakabayashi I
Brain Res Mol Brain Res; 1995 Nov; 33(2):305-10. PubMed ID: 8750890
[TBL] [Abstract][Full Text] [Related]
36. The effects of morphine on carrageenin-induced spinal c-Fos expression are completely blocked by beta-funaltrexamine, a selective mu-opioid receptor antagonist.
Honoré P; Buritova J; Besson JM
Brain Res; 1996 Sep; 732(1-2):242-6. PubMed ID: 8891291
[TBL] [Abstract][Full Text] [Related]
37. Mercaptoacetate induces feeding through central opioid-mediated mechanisms in rats.
Stein JA; Znamensky V; Baumer F; Rossi GC; Pasternak GW; Bodnar RJ
Brain Res; 2000 May; 864(2):240-51. PubMed ID: 10802031
[TBL] [Abstract][Full Text] [Related]
38. Effect of naloxone on ischemic acute kidney injury in the mouse.
Mutoh J; Ohsawa M; Hisa H
Neuropharmacology; 2013 Aug; 71():10-8. PubMed ID: 23523991
[TBL] [Abstract][Full Text] [Related]
39. Central µ-Opioid Receptor Antagonism Blocks Glucoprivic LH Pulse Suppression and Gluconeogenesis/Feeding in Female Rats.
Tsuchida H; Kawai N; Yamada K; Takizawa M; Inoue N; Uenoyama Y; Tsukamura H
Endocrinology; 2021 Oct; 162(10):. PubMed ID: 34270714
[TBL] [Abstract][Full Text] [Related]
40. The effect of blockade of kappa-opioid receptors in the medial preoptic area on the luteinizing hormone surge in the proestrous rat.
Smith MJ; Gallo RV
Brain Res; 1997 Sep; 768(1-2):111-9. PubMed ID: 9369307
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
